Corindus Vascular Robotics Inc. appointed James Tobin to its board, effective immediately.
Tobin was the CEO of Boston Scientific Corp. from 1999 to 2009, a period that saw the company's revenues grow from nearly $2 billion to over $8 billion.
Tobin, who also serves on the boards of Oxford Immunotec Global PLC and Globus Medical Inc., is expected to help the Waltham, Mass.-based medical device maker in accelerating its business.
